Related Experiment Video
Updated: Sep 30, 2026

Ultrasound-Guided Induced Pluripotent Stem Cell-Derived Cardiomyocyte Implantation in Myocardial Infarcted Mice
Published on: March 30, 2022
[Familial dilated cardiomyopathy in patients transplanted for idiopathic dilated cardiomyopathy]
Lorenzo Monserrat1, Manuel Hermida, Beatriz Bouzas
1Servicio de Cardiología del Hospital Juan Canalejo, A Coruña, Spain. Lorenzo_Monserrat@cannalejo.org
Insights
Familial dilated cardiomyopathy (DCM) is common in heart transplant recipients. Early signs like left ventricular enlargement and conduction defects may indicate familial disease.
Area of Science:
- Cardiology
- Genetics
- Transplantation Medicine
Background:
- Dilated cardiomyopathy (DCM) is a significant cause of heart failure requiring transplantation.
- Understanding the genetic basis of DCM is crucial for risk stratification and family screening.
Purpose of the Study:
- To determine the prevalence of familial DCM in heart transplant patients.
- To characterize the clinical features and inheritance patterns of familial DCM.
- To identify potential early markers for familial DCM.
Main Methods:
- Studied 43 families with heart transplant recipients diagnosed with idiopathic DCM.
- Excluded patients with a history of alcohol abuse.
- Conducted clinical evaluations, ECGs, echocardiograms, blood tests, and DNA analysis in patients and relatives.
Main Results:
- Familial DCM was identified in 25.6% of probands, and possible familial DCM in another 25.6%.
- Fifteen relatives had DCM, 26 had left ventricular enlargement (LVE), and 5 had hypertrophic cardiomyopathy.
- Autosomal dominant inheritance was most common, with some cases suggesting recessive inheritance and others showing conduction system defects.
Conclusions:
- Familial DCM has a high prevalence in heart transplant candidates.
- LVE, conduction abnormalities, and elevated creatine kinase may serve as early indicators of familial DCM.
- Hypertrophic cardiomyopathy and familial DCM can be present even in patients with a prior diagnosis of alcoholic DCM.
Objective:
To evaluate the prevalence, clinical features, and pattern of inheritance of familial dilated cardiomyopathy (DCM) in heart transplant patients.
Patients And Method:
Patients with idiopathic DCM who had undergone heart transplantation were invited to participate. Patients with alcohol abuse were excluded. A clinical evaluation, 12-lead ECG, echocardiogram, blood tests, and DNA extraction were performed in patients and relatives. Familial DCM was defined as the presence of at least one relative with idiopathic DCM. Possible familial DCM was considered when at least one relative had left ventricular enlargement (LVE) (> 112% predicted LVEDD).
Results:
One hundred and ninety-nine relatives of 43 families were studied. DCM was familial in 11 probands (25.6%) and possibly familial in 11 (25.6%). Fifteen relatives had DCM (7.5%), 26 (13.1%) LVE, and 5 (2.5%) hypertrophic cardiomyopathy. The pattern of inheritance was autosomal dominant in most families. Five probands (3 with familial DCM) had antecedents of consanguinity and possible recessive inheritance. Six probands (14%, 1 with familial DCM) had relatives with conduction system defects. Creatine kinase was moderately increased in 9 relatives (4.5%), 3 of them with LVE. Fifteen patients had at least moderate alcohol intake. Three of them had familial DCM (relatives without alcohol abuse) and 6 had possible familial DCM.
Conclusions:
The prevalence of familial DCM is high in patients who undergo heart transplant. Left ventricular enlargement, conduction system abnormalities, and elevated creatine kinase may be early markers of familial disease. Hypertrophic cardiomyopathy is present in some relatives of patients with idiopathic DCM. Familial DCM is present in patients with a previous diagnosis of alcoholic DCM.
Related Concept Videos
Cardiomyopathy II: Dilated Cardiomyopathy
Cardiomyopathy V: Interprofessional Care
Cardiomyopathy III: Hypertrophic Cardiomyopathy
Cardiomyopathy IV: Restrictive Cardiomyopathy
Tissue Transplantation
The Biology of Tissue Transplantation
The biology of tissue transplantation hinges on the Major Histocompatibility Complex (MHC) molecules. These molecules...
Cardiomyopathy I: Introduction and Classification

